KM Research Hub

LITERATURE

原始候选快照

v3 复核前的候选池,完整保留,仅供查看,不会自动重新处理。 共 7004 篇。

导出 CSV
论文标识日期入排置信度入排依据KM 状态
Abemaciclib plus fulvestrant in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in premenopausal women: subgroup analysis from the MONARCH 2 trial.Breast Cancer ResPMID 34425869PMC83815812021-Aug-230.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Randomized Phase II Study to Comparing Docetaxel/Nedaplatin versus Docetaxel for 5-Fluorouracil/Cisplatin Resistant Esophageal Squamous Cell Carcinoma.Ann Thorac Cardiovasc SurgPMID 33408308PMC83740902021-Aug-200.96明确的 Phase III/IIIb/II-III 随机肿瘤药物试验,且报告 time-to-event 结局。待处理
Low-pressure versus standard pressure laparoscopic colorectal surgery (PAROS trial): a phase III randomized controlled trial.Br J SurgPMID 33755088无 PMCID2021-Aug-190.93干预为非药物单独策略,未满足药物干预要求。待处理
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.N Engl J MedPMID 34407342无 PMCID2021-Aug-190.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Atogepant for the Preventive Treatment of Migraine.N Engl J MedPMID 34407343无 PMCID2021-Aug-190.98未发现恶性肿瘤人群证据。待处理
Bacterial Mucosal Immunotherapy with MV130 Prevents Recurrent Wheezing in Children: A Randomized, Double-Blind, Placebo-controlled Clinical Trial.Am J Respir Crit Care MedPMID 33705665PMC84802402021-Aug-150.98未发现恶性肿瘤人群证据。待处理
Efficacy and safety of chiglitazar, a novel peroxisome proliferator-activated receptor pan-agonist, in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 3 trial (CMAP).Sci Bull (Beijing)PMID 36654286无 PMCID2021-Aug-150.98未发现恶性肿瘤人群证据。待处理
Chiglitazar monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomized, double-blind, phase 3 trial (CMAS).Sci Bull (Beijing)PMID 36654287无 PMCID2021-Aug-150.98未发现恶性肿瘤人群证据。待处理
Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial.LancetPMID 34370970无 PMCID2021-Aug-140.98未发现恶性肿瘤人群证据。待处理
Ceftolozane/tazobactam versus meropenem in patients with ventilated hospital-acquired bacterial pneumonia: subset analysis of the ASPECT-NP randomized, controlled phase 3 trial.Crit CarePMID 34380538PMC83562112021-Aug-110.98未发现恶性肿瘤人群证据。待处理
Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131.J Clin OncolPMID 34092112PMC85776882021-Aug-100.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma.BMC CancerPMID 34364385PMC83494892021-Aug-070.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.N Engl J MedPMID 34170647无 PMCID2021-Aug-050.98未发现恶性肿瘤人群证据。待处理
Comparing Patient-Controlled Analgesia Versus Non-PCA Hydromorphone Titration for Severe Cancer Pain: A Randomized Phase III Trial.J Natl Compr Canc NetwPMID 34343968无 PMCID2021-Aug-030.95While the record meets many criteria (Phase III, randomized, human, oncology context, time-to-event endpoint, original results), the intervention (hydromorphone for pain control) is a supportive care measure for cancer pain, not an anti-neoplastic drug therapy aimed at treating the malignant neoplasm itself. The cohort requires a drug-containing intervention for the oncology indication.待处理
Long-term efficacy and safety of sapropterin in patients who initiated sapropterin at < 4 years of age with phenylketonuria: results of the 3-year extension of the SPARK open-label, multicentre, randomised phase IIIb trial.Orphanet J Rare DisPMID 34344399PMC83358972021-Aug-030.98未发现恶性肿瘤人群证据。待处理
Neurocognitive functioning and radiologic changes in primary CNS lymphoma patients: results from the HOVON 105/ALLG NHL 24 randomized controlled trial.Neuro OncolPMID 33560442PMC83280302021-Aug-020.95The record is from a phase III randomized oncology trial (HOVON 105/ALLG NHL 24) but reports neurocognitive and radiological outcomes only. It does not contain the required survival, progression, recurrence, death, or time-to-event efficacy outcomes for KM digitization.待处理
Comparative Efficacy of a High-Dose vs Standard-Dose Hepatitis B Revaccination Schedule Among Patients With HIV: A Randomized Clinical Trial.JAMA Netw OpenPMID 34424307PMC83831372021-Aug-020.98未发现恶性肿瘤人群证据。待处理
A Randomized Controlled Trial of Local Delivery of a Rho Inhibitor (VX-210) in Patients with Acute Traumatic Cervical Spinal Cord Injury.J NeurotraumaPMID 33559524PMC83094352021-Aug-010.98未发现恶性肿瘤人群证据。待处理
Long-Term Outcomes of Radical Radiation Therapy with Hypoxia Modification with Biomarker Discovery for Stratification: 10-Year Update of the BCON (Bladder Carbogen Nicotinamide) Phase 3 Randomized Trial (ISRCTN45938399).Int J Radiat Oncol Biol PhysPMID 33689854无 PMCID2021-Aug-010.80The trial meets criteria for oncology, human, randomized, Phase III, time-to-event endpoint, and original long-term results. However, the intervention (carbogen and nicotinamide for hypoxia modification) is not considered a conventional drug intervention as per the inclusion criteria, which requires a drug-containing intervention (e.g., cytotoxic, targeted, immunotherapy).待处理
Resolution of organ dysfunction as a predictor of long-term survival in necrotizing soft tissue infections: Analysis of the AB103 Clinical Composite Endpoint Study in Necrotizing Soft Tissue Infections trial and a retrospective claims database-linked chart study.J Trauma Acute Care SurgPMID 33797490无 PMCID2021-Aug-010.98未发现恶性肿瘤人群证据。待处理
Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance).J Clin OncolPMID 33989025PMC84625872021-Aug-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer.Clin Cancer ResPMID 34083231PMC89744212021-Aug-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma.J Clin OncolPMID 34111952无 PMCID2021-Aug-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Long-term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma: The NEOCRTEC5010 Randomized Clinical Trial.JAMA SurgPMID 34160577PMC82231382021-Aug-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Effect of Postoperative Radiotherapy for Patients With pIIIA-N2 Non-Small Cell Lung Cancer After Complete Resection and Adjuvant Chemotherapy: The Phase 3 PORT-C Randomized Clinical Trial.JAMA OncolPMID 34165501PMC82274502021-Aug-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Prognosis of Patients With Early Breast Cancer Receiving 5 Years vs 2 Years of Adjuvant Bisphosphonate Treatment: A Phase 3 Randomized Clinical Trial.JAMA OncolPMID 34165508PMC82274652021-Aug-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Quadrivalent Human Papillomavirus Vaccine in Boys and Girls 9-13 Years of Age in Malaysia: A Phase IIIb, Randomized, Open-label Study.Pediatr Infect Dis JPMID 34250977PMC82745802021-Aug-010.98未发现恶性肿瘤人群证据。待处理
Serious Gastrointestinal-Related Adverse Events Among Psoriasis Patients Treated With Guselkumab in VOYAGE 1 and VOYAGE 2.J Drugs DermatolPMID 34397205无 PMCID2021-Aug-010.98未发现恶性肿瘤人群证据。待处理
Fixed-Combination Halobetasol Propionate/Tazarotene Lotion for Psoriasis in Patients With 3%-5% Affected Body Surface Area.J Drugs DermatolPMID 34397206无 PMCID2021-Aug-010.98未发现恶性肿瘤人群证据。待处理
Cost-effectiveness of nivolumab in patients with NSCLC in the United States.Am J Manag CarePMID 34460179无 PMCID2021-Aug-010.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Consistent response to guselkumab treatment between Hispanic and non-Hispanic patients with psoriasis: an analysis from VOYAGE 1 and VOYAGE 2.J Dermatolog TreatPMID 31613178无 PMCID2021-Aug0.98未发现恶性肿瘤人群证据。待处理
Efficacy and safety of neuronox® for lateral canthal lines: a phase I/III, multicenter, randomized, double-blind, active-controlled study.J Dermatolog TreatPMID 31665942无 PMCID2021-Aug0.98未发现恶性肿瘤人群证据。待处理
Randomized Trials of Retosiban Versus Placebo or Atosiban in Spontaneous Preterm Labor.Am J PerinatolPMID 32380566无 PMCID2021-Aug0.98未发现恶性肿瘤人群证据。待处理
Long-term efficacy and safety of ixekizumab: A 5-year analysis of the UNCOVER-3 randomized controlled trial.J Am Acad DermatolPMID 33253833无 PMCID2021-Aug0.98未发现恶性肿瘤人群证据。待处理
Effect of the novel dual orexin receptor antagonist daridorexant on night-time respiratory function and sleep in patients with moderate chronic obstructive pulmonary disease.J Sleep ResPMID 33417730无 PMCID2021-Aug0.98未发现恶性肿瘤人群证据。待处理
A glycopyrronium bromide 1% cream for topical treatment of primary axillary hyperhidrosis: efficacy and safety results from a phase IIIa randomized controlled trial.Br J DermatolPMID 33445205PMC84518662021-Aug0.98未发现恶性肿瘤人群证据。待处理
Efficacy of once-daily glucagon-like peptide-1 receptor agonist lixisenatide as an add-on treatment to basal insulin in Asian and white adults with type 2 diabetes mellitus: An individual-level pooled analysis of phase III studies.J Diabetes InvestigPMID 33475222PMC83545052021-Aug0.98未发现恶性肿瘤人群证据。待处理
Long-term outcome of imatinib 400 mg compared to imatinib 600 mg or imatinib 400 mg daily in combination with cytarabine or pegylated interferon alpha 2a for chronic myeloid leukaemia: results from the French SPIRIT phase III randomised trial.LeukemiaPMID 33483613无 PMCID2021-Aug0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Romosozumab efficacy on fracture outcomes is greater in patients at high baseline fracture risk: a post hoc analysis of the first year of the frame study.Osteoporos IntPMID 33537844PMC83767322021-Aug0.98未发现恶性肿瘤人群证据。待处理
Biomarkers associated with blinatumomab outcomes in acute lymphoblastic leukemia.LeukemiaPMID 33542479PMC83244762021-Aug0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Five-year efficacy and safety of tildrakizumab in patients with moderate-to-severe psoriasis who respond at week 28: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2).Br J DermatolPMID 33544883无 PMCID2021-Aug0.98未发现恶性肿瘤人群证据。待处理
Effects of glutamine for prevention of radiation-induced esophagitis: a double-blind placebo-controlled trial.Invest New DrugsPMID 33580845PMC119484882021-Aug0.95The trial is randomized, Phase III, in oncology patients, and evaluates a drug intervention (glutamine). However, the primary endpoint is the incidence and severity of radiation-induced esophagitis, which is a toxicity/preventive endpoint, not a time-to-event efficacy endpoint such as overall survival, progression-free survival, or disease-free survival. The abstract does not report Kaplan-Meier curves or hazard ratios for such an endpoint.待处理
A Phase III Randomized Study of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, for Active Ankylosing Spondylitis.J RheumatolPMID 33589554无 PMCID2021-Aug0.98未发现恶性肿瘤人群证据。待处理
First-line Treatment with Ribociclib plus Endocrine Therapy for Premenopausal Women with Hormone-receptor-positive Advanced Breast Cancer: A Cost-effectiveness Analysis.Clin Breast CancerPMID 33676870无 PMCID2021-Aug0.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
EVO100 prevents chlamydia and gonorrhea in women at high risk of infection.Am J Obstet GynecolPMID 33705748无 PMCID2021-Aug0.98未发现恶性肿瘤人群证据。待处理
Ribociclib Population Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Analysis of Neutrophils in Cancer Patients.J Clin PharmacolPMID 33713359无 PMCID2021-Aug0.85The record is a Phase III randomized trial in oncology with a drug intervention, but it reports only pharmacokinetic and pharmacodynamic modeling for safety (neutropenia), not primary or key secondary time-to-event efficacy outcomes like OS or PFS. Therefore, it does not meet the inclusion criterion for a time-to-event efficacy endpoint.待处理
Secukinumab Efficacy on Enthesitis in Patients With Ankylosing Spondylitis: Pooled Analysis of Four Pivotal Phase III Studies.J RheumatolPMID 33722947无 PMCID2021-Aug0.98未发现恶性肿瘤人群证据。待处理
pUDK-HGF Gene Therapy to Relieve CLI Rest Pain and Ulcer: A Phase II, Double-Blind, Randomized Placebo-Controlled Trial.Hum Gene TherPMID 33726499无 PMCID2021-Aug0.98未发现恶性肿瘤人群证据。待处理
Henagliflozin as add-on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial.Diabetes Obes MetabPMID 33769656无 PMCID2021-Aug0.98未发现恶性肿瘤人群证据。待处理
Efficacy and safety of LY2963016 insulin glargine versus insulin glargine (Lantus) in Chinese adults with type 2 diabetes: A phase III, randomized, open-label, controlled trial.Diabetes Obes MetabPMID 33783964PMC83617362021-Aug0.98未发现恶性肿瘤人群证据。待处理